Dr. Michael J. Dans, MD
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- New York University School of Medicine (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 658
Licensed in California since 2004, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: New York University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
CA license A89288 (first issued 2004; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- San Francisco Dermatology, Inc. (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 658
- Services billed
- 5,695
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 2,641 | 303 |
| Established patient office or other outpatient visit, 20-29 minutes | 881 | 524 |
| Destruction of precancer skin growth, 1 growth | 550 | 360 |
| Destruction of skin growth, 1-14 growths | 254 | 197 |
| Biopsy of related skin growth, first growth | 184 | 164 |
| Established patient office or other outpatient visit, 30-39 minutes | 120 | 85 |
| Destruction of precancer skin growth, 15 or more growths | 87 | 56 |
| New patient office or other outpatient visit, 30-44 minutes | 75 | 75 |
| Established patient office or other outpatient visit, 10-19 minutes | 68 | 63 |
| Biopsy of related skin growth, each additional growth | 52 | 36 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Triamcinolone Acetonide Other prescribers in San Francisco, CA | 113 |
| Ketoconazole Other prescribers in San Francisco, CA | 91 |
| Clobetasol Propionate Other prescribers in San Francisco, CA | 76 |
| Gabapentin Other prescribers in San Francisco, CA | 64 |
| Fluorouracil Other prescribers in San Francisco, CA | 53 |
| Doxycycline Hyclate Other prescribers in San Francisco, CA | 47 |
| Betamethasone Diprop Augmented (betamethasone/propylene glyc) | 45 |
| Fluocinonide Other prescribers in San Francisco, CA | 38 |
| Hydrocortisone Other prescribers in San Francisco, CA | 32 |
| Metronidazole Other prescribers in San Francisco, CA | 27 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.